We are live on ! Find out more
FIS

FCPM III Services Portfolio holdings

AUM $722M
1-Year Est. Return 73.61%
This Fund
S&P 500
This Quarter Est. Return
-10.61%
1 Year Est. Return
+73.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$369M
AUM Growth
-$44.6M
Cap. Flow
-$791K
Cap. Flow %
-0.21%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
RAPT
RAPT Therapeutics
RAPT
+$3.36M
2
ATXS
Astria Therapeutics
ATXS
+$1.38M

Top Sells

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$5.53M

Sector Composition

Rank Sector Weight
1 Healthcare 99.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$3.47B
$193M 52.16%
10,632,113
-303,197
-3% -$5.53M
DYN icon
2
Dyne Therapeutics
DYN
$3.88B
$52M 14.09%
5,462,846
– –
REPL icon
3
Replimune Group
REPL
$882M
$36.3M 9.84%
3,909,696
– –
ENGN icon
4
enGene Therapeutics
ENGN
$125M
$35.1M 9.5%
9,632,561
– –
BCYC
5
Bicycle Therapeutics
BCYC
$290M
$24M 6.5%
3,452,330
– –
ATXS
6
DELISTED
Astria Therapeutics
ATXS
$23.4M 6.34%
4,107,537
+285,000
+7% +$1.38M
RAPT
7
DELISTED
RAPT Therapeutics
RAPT
$3.45M 0.93%
+440,176
New +$3.36M
ENGNW icon
8
enGene Therapeutics Warrants
ENGNW
$3.53M
$2.36M 0.64%
2,878,148
– –

Similar funds

ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
ZAM
Zevin Asset Management Boston, Massachusetts $723M AUM 15.62% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $723M AUM 24.23% 1-Year Est. Return
UW
Unique Wealth Clearwater, Florida $723M AUM 16.35% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
FFM
FengHe Fund Management Singapore $724M AUM 196.18% 1-Year Est. Return
WLIM
White Lighthouse Investment Management Bedford, Massachusetts $721M AUM 16.12% 1-Year Est. Return

FCPM III Services's Q2 2025 Portfolio in Review

As of Q2 2025, FCPM III Services held 8 positions worth $369M, down 11% from $414M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

FCPM III Services's Q2 2025 filing shows 1 new, 1 increased and 1 reduced positions. Its largest new stake was RAPT Therapeutics: 440,176 shares worth $3.45M. The largest sale was NewAmsterdam Pharma, an estimated $5.53M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

  • FCPM III Services's largest Q2 2025 buy was RAPT Therapeutics: 440,176 shares worth $3.45M.
  • FCPM III Services added most to Astria Therapeutics in Q2 2025, an estimated $1.38M increase.
  • FCPM III Services's biggest Q2 2025 reduction was NewAmsterdam Pharma, cutting an estimated $5.53M.
  • FCPM III Services's ten largest holdings make up 100% of its $369M portfolio in Q2 2025.
  • FCPM III Services opened 1 new position and closed 0 in Q2 2025.
  • FCPM III Services's portfolio value fell 11% quarter-over-quarter to $369M.

Based on FCPM III Services's 13F filing for Q2 2025, filed 14 Aug 2025.